Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Rimonabant to Reduce Alcohol Consumption [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for rimonabant aimed at reducing alcohol consumption, including healthy volunteers and individuals who drink alcohol; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rimonabant (rimonabant)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Healthy, Alcohol Drinking | Phase 2 | Status: COMPLETED